The PAI-1 4G/5G and ACE I/D Polymorphisms and Risk of Recurrent Pregnancy Loss: A Case-Control Study

被引:21
|
作者
Kim, Jin Ju [1 ,2 ]
Choi, Young Min [2 ,3 ]
Lee, Sung Ki [4 ]
Yang, Kwang Moon [5 ,6 ]
Paik, Eun Chan [7 ]
Jeong, Hyeon Jeong [8 ]
Jun, Jong Kwan [3 ]
Han, Ae Ra [9 ]
Hong, Min A. [3 ]
机构
[1] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Obstet & Gynecol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Inst Reprod Med & Populat, Med Res Ctr, Coll Med, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 110744, South Korea
[4] Konyang Univ, Dept Obstet & Gynecol, Coll Med, Taejon, South Korea
[5] Kwandong Univ, Cheil Gen Hosp, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea
[6] Kwandong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea
[7] Bundangcheil Womens Hosp, Dept Obstet & Gynecol, Bundang, South Korea
[8] Seoul Rachel Fertil Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[9] Kyungpook Natl Univ, Dept Obstet & Gynecol, Coll Med, Taegu, South Korea
关键词
Angiotensin converting enzyme; plasminogen activator inhibitor type 1; recurrent pregnancy loss; single-nucleotide polymorphisms; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ANGIOTENSIN-CONVERTING ENZYME; GENETIC ASSOCIATION; MISCARRIAGE; WOMEN; EXPRESSION; GENOTYPE; SYSTEM;
D O I
10.1111/aji.12302
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ProblemThrombophilia has been postulated to be a contributor to the pathophysiology of recurrent pregnancy loss (RPL). We investigated the role of the plasminogen activator inhibitor type 1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D polymorphisms in Korean patients with RPL. Method of studyGenotyping was performed using the TaqMan assay in 227 RPL patients and 304 controls. ResultsThe genotype distributions of both polymorphisms in the RPL group did not differ from those of controls. Because the frequency of being homozygous for ACE D/D and the PAI-I 4G/4G combination has been reported to be significantly higher in RPL patients, this was also analyzed. However, no significant difference was noted; 3.1% of RPL patients had both ACE D/D and PAI-I 4G/4G, as did 4.9% of controls (P=0.791). ConclusionThe current study suggests that both polymorphisms, either alone or in combination, are not major determinants of the development of RPL in Korean women.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 50 条
  • [1] A meta-analysis of the association of the ACE I/D and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Iranian women: Are the investigations adequate?
    Dastgheib, Seyed Alireza
    Karimi-Zarchi, Mojgan
    Bahrami, Reza
    Tabatabaei, Razieh Sadat
    Javaheri, Atiyeh
    Noorishadkam, Mahmood
    Mirjalili, Seyed Reza
    Neamatzadeh, Hossein
    [J]. TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 18 (02) : 139 - 150
  • [2] Is there an interaction between the ACE I/D and the PAI-1 4G/5G gene polymorphisms on risk of myocardial infarction?
    Hebert, PR
    Coffey, CS
    Ajani, UA
    Morgan, TM
    Brown, NJ
    Vaughan, DE
    Ridker, PM
    [J]. CIRCULATION, 2001, 104 (17) : 809 - 809
  • [3] Interrelationship between ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 antigen levels in healthy subjects
    dAddedda, M
    Cappucci, G
    Colaizzo, D
    Giuliani, N
    Vecchione, G
    Grandone, E
    Margaglione, M
    DiMinno, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : O1594 - O1594
  • [4] Association of ACE I/D and PAI-1 4G/5G polymorphisms with susceptibility to type 2 diabetes mellitus
    Miri, Somaye
    Sheikhha, Mohammad Hasan
    Dastgheib, Seyed Alireza
    Shaker, Seyed Amir
    Neamatzadeh, Hossein
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2021, 20 (02) : 1191 - 1197
  • [5] Association of ACE I/D and PAI-1 4G/5G polymorphisms with susceptibility to type 2 diabetes mellitus
    Somaye Miri
    Mohammad Hasan Sheikhha
    Seyed Alireza Dastgheib
    Seyed Amir Shaker
    Hossein Neamatzadeh
    [J]. Journal of Diabetes & Metabolic Disorders, 2021, 20 : 1191 - 1197
  • [6] Combinatorial partitioning reveals interactive effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levels.
    Lamb, JM
    Brown, NJ
    Baker, MT
    Gainer, JV
    Richardson, KR
    Connolly, D
    Gupta, A
    Vaughan, DE
    Moore, JH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 52 - 52
  • [7] Lack of association between I/D ACE and-675 ID 4G / 5G PAI-1 polymorphisms and predicting risk of pregnancy loss (PROPALO) in Bosnian women
    Emir, Mahmutbegovic
    Karolina, Skonieczna-Zydecka
    Amina, Valjevac
    Nevena, Mahmutbegovic
    Anna, Pawinska-Matecka
    Ewa, Czerska
    Damir, Marjanovic
    Grazyna, Adler
    [J]. PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING 2017 (CMBEBIH 2017), 2017, 62 : 440 - 444
  • [8] Coexistence of ACE (I/D) and PAI-1(4G/5G) gene variants in recurrent miscarriage in Polish population
    Kurzawinska, Grazyna
    Barlik, Magdalena
    Drews, Krzysztof
    Rozycka, Agata
    Seremak-Mrozikiewicz, Agnieszka
    Oarowski, Marcin
    Klejewski, Andrzej
    Czerny, Boguslaw
    Wolski, Hubert
    [J]. GINEKOLOGIA POLSKA, 2016, 87 (04) : 271 - 276
  • [9] 4G/5G polymorphisms of PAI-1 in the metabolic syndrome
    Roncal, C
    Orbe, J
    Rodríguez, JA
    Páramo, JA
    [J]. MEDICINA CLINICA, 2006, 126 (06): : 234 - 234
  • [10] The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
    Zivkovic, Maja
    Cizmarevic, Nada Starcevic
    Lovrecic, Luca
    Klupka-Saric, Inge
    Stankovic, Aleksandra
    Gasparovic, Iva
    Lavtar, Polona
    Dincic, Evica
    Stojkovic, Ljiljana
    Rudolf, Gorazd
    Jazbec, Sasa Sega
    Perkovic, Olivio
    Sinanovic, Osman
    Sepcic, Juraj
    Kapovic, Miljenko
    Peterlin, Borut
    Ristic, Smiljana
    [J]. DISEASE MARKERS, 2014, 2014